首页> 外文期刊>Current drug therapy >Buccoadhesive Dosage Form Containing Antifungal Agent for Treating Oropharyngeal Candidiasis:A Review One More Buccoadhesive Antifungal for Oropharyngeal Candidiasis
【24h】

Buccoadhesive Dosage Form Containing Antifungal Agent for Treating Oropharyngeal Candidiasis:A Review One More Buccoadhesive Antifungal for Oropharyngeal Candidiasis

机译:含抗真菌剂的颊粘膜剂型治疗口咽念珠菌病:综述另一种口咽念珠菌病

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dear Editor,In the above mentioned review article, a comprehensive list of active ingredients investigated in bioadhesive dosage forms for the treatment of OPC was presented, various kind of active agents and dosage forms have been mentioned but one agent Miconazole base is omitted. The active ingredients are Miconazole 50 mg buccal tablet (MBT) (Oravig?, Strativa Pharmaceuticals). Miconazole nitrate 10 mg buccal tablets (Tibozole?, Tibotec Pharmaceuticals) The above mentioned buccal tablets were used in the treatment for OPC. However, the two miconazole buccal tablets are distinct products, and each contains different polymers. MBT utilizes a hydrophilic matrix containing the polymer hypermellose, which allows immediate and sustained release of Miconazole [1].
机译:亲爱的编辑,在上述评论文章中,列出了用于治疗OPC的生物粘附剂型中研究的活性成分的完整列表,提到了各种活性剂和剂型,但省略了一种药物咪康唑碱。活性成分是咪康唑50 mg颊片(MBT)(Oravig?,Strativa Pharmaceuticals)。硝酸咪康唑10mg颊片(Tibozole?,Tibotec Pharmaceuticals)将上述颊片用于OPC的治疗。但是,两种咪康唑口腔片剂是截然不同的产品,每种都包含不同的聚合物。 MBT利用含有聚合物高果胶的亲水性基质,可以立即和持续释放咪康唑[1]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号